Recombinant Enterococcus faecalis 30S ribosomal protein S7 (rpsG)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rpsG; EF_0199; 30S ribosomal protein S7
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-156
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Enterococcus faecalis (strain ATCC 700802 / V583)
Target Names
rpsG
Target Protein Sequence
MPRKGPVAKR DVLPDPIYNS KLVTRLINRV MVDGKRGIAA NIIYNSFDII KESTGNDPLE VFEQAMKNVM PVLEVKARRV GGSNYQVPVE VRPERRTTLG LRWVVNYARL RGEHTMEERL AKEIMDAANN TGASVKKRED THKMADANRA FAHYRW
Uniprot No.

Target Background

Function
A key rRNA-binding protein, it directly interacts with 16S rRNA, nucleating the assembly of the 30S ribosomal subunit's head domain. Its location at the subunit interface, near the decoding center, likely inhibits E-site tRNA exit.
Database Links

KEGG: efa:EF0199

STRING: 226185.EF0199

Protein Families
Universal ribosomal protein uS7 family

Q&A

What is the fundamental role of 30S ribosomal protein S7 (rpsG) in Enterococcus faecalis?

RpsG is one of the primary rRNA binding proteins in the 30S ribosomal subunit of E. faecalis. It binds directly to 16S rRNA where it nucleates assembly of the head domain of the 30S subunit. The protein is located at the subunit interface close to the decoding center, where it has been shown to contact mRNA. Additionally, it contacts tRNA in both the P and E sites and likely blocks exit of the E site tRNA .

In Enterococcus faecalis, rpsG (gene product EF0199) is primarily localized in the cytoplasm, as identified in surface protein analysis studies . Its conserved function across bacterial species underscores its essential role in ribosome assembly and function, making it an interesting target for basic research on bacterial translation mechanisms.

How does rpsG structure compare between E. faecalis and other bacterial species?

While specific structural data on E. faecalis rpsG is limited, comparative studies on ribosomal proteins show species-specific features that may influence functionality. For instance, structural studies on Staphylococcus aureus ribosomal proteins revealed unique extended loops and conformational differences in certain ribosomal proteins compared to other bacterial species .

In the case of rpsG, the protein maintains conserved functional domains across different bacterial species, but subtle structural differences may exist, particularly in surface-exposed regions. These variations could contribute to species-specific ribosomal assembly pathways or translation regulation mechanisms in E. faecalis.

FeatureE. faecalis rpsGE. coli rpsGS. aureus rpsG
Molecular Weight~23.9 kDa23.9 kDa (confirmed)~24 kDa
Primary binding16S rRNA16S rRNA16S rRNA
LocationSubunit interface, decoding centerSubunit interface, decoding centerSubunit interface, decoding center
Species-specific interactionsUnder investigationWell-characterizedShows unique properties

What are the optimal conditions for recombinant expression of E. faecalis rpsG?

Based on established protocols for ribosomal proteins, E. faecalis rpsG is typically expressed in E. coli expression systems. The following methodological approach has proven effective:

  • Vector selection: pET-based expression vectors with T7 promoter systems offer high yield expression.

  • Host strain: E. coli BL21(DE3) or derivatives like Rosetta(DE3) are recommended, especially if E. faecalis codon usage differs significantly from E. coli.

  • Induction conditions: IPTG induction (0.2-1.0 mM) at 16-18°C overnight typically produces better soluble protein than higher temperature induction.

  • Buffer optimization: Since rpsG is an RNA-binding protein, maintaining moderate ionic strength (200-300 mM NaCl) in purification buffers is critical to reduce non-specific binding to nucleic acids .

For optimal results, researchers should include a purification tag such as 6×His that can be subsequently removed using a specific protease cleavage site. Purification typically follows a multi-step process involving IMAC (immobilized metal affinity chromatography) followed by ion exchange and/or size exclusion chromatography.

How can researchers validate the functional activity of purified recombinant rpsG?

Validating the functional activity of recombinant rpsG requires multiple approaches:

  • RNA binding assays: Electrophoretic mobility shift assays (EMSA) with 16S rRNA fragments containing the known rpsG binding site.

  • In vitro translation: Measuring the ability of the purified protein to complement 30S subunits lacking rpsG in in vitro translation systems.

  • Ribosome assembly assays: Testing the protein's capacity to facilitate assembly of the 30S ribosomal head domain using purified ribosomal components.

  • Structural integrity verification: Circular dichroism spectroscopy and thermal shift assays to confirm proper folding and stability.

When using tagged constructs, it's critical to verify that the tag doesn't interfere with RNA binding activity. Comparisons between tagged and untagged versions (after tag removal) in binding assays can address this concern.

How can recombinant rpsG be used to study RNA-protein complexes in E. faecalis?

Recent Grad-seq (gradient profiling by sequencing) analyses of E. faecalis have provided comprehensive insights into RNA-protein complexes, including those involving ribosomal proteins . Researchers can use recombinant rpsG in several approaches:

  • Pull-down experiments: Immobilized recombinant rpsG can be used to identify interacting RNAs and proteins from E. faecalis lysates.

  • Crosslinking studies: Methods like UV crosslinking followed by immunoprecipitation (CLIP) using antibodies against recombinant rpsG can identify direct RNA interactions in vivo.

  • Reconstitution experiments: Recombinant rpsG can be used in reconstitution experiments to study the assembly dynamics of the 30S ribosomal subunit.

  • Competition assays: To determine binding specificity, researchers can perform competition assays between different RNA species for recombinant rpsG binding.

The Grad-seq approach has successfully identified a cluster of sRNAs in E. faecalis that sediment in 30S ribosomal fractions, indicating potential functional interactions with the translation machinery . These findings provide a foundation for investigating specific interactions with rpsG.

What role does rpsG play in antibiotic resistance mechanisms in E. faecalis?

While specific mutations in rpsG of E. faecalis have not been directly linked to antibiotic resistance in the provided search results, studies on related organisms suggest potential involvement:

  • Ribosomal proteins, including those in the 30S subunit, are known targets for various antibiotics. Modifications or mutations in these proteins can contribute to antibiotic resistance mechanisms.

  • Recent studies on omadacycline efficacy against E. faecalis examined resistance mechanisms involving the 30S ribosomal subunit. Although specific rpsG mutations were not identified, investigations focused on examining 30S ribosomal subunit genes to understand heteroresistance mechanisms .

  • Research methodology for investigating rpsG's role in antibiotic resistance should include:

    • Generating point mutations in recombinant rpsG based on known resistance mutations in other species

    • Performing in vitro translation assays with various antibiotics to measure the impact of these mutations

    • Developing complementation systems to introduce mutated rpsG into E. faecalis to assess in vivo resistance phenotypes

What methodologies are recommended for studying rpsG interactions with small RNAs in E. faecalis?

Given the recent identification of various small RNAs (sRNAs) in E. faecalis and their important roles in stress response and pathogenesis , investigating interactions between rpsG and sRNAs represents an exciting research direction. Recommended methodologies include:

  • RNA-protein interaction mapping:

    • RNA Electrophoretic Mobility Shift Assays (REMSA) with purified recombinant rpsG and candidate sRNAs

    • Surface Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC) to determine binding kinetics and affinities

    • CLIP-seq (Crosslinking and Immunoprecipitation followed by sequencing) to identify in vivo interactions

  • Functional validation:

    • Testing translational effects of identified sRNAs in systems with wild-type versus mutant rpsG

    • In vitro translation assays with reconstituted ribosomes containing recombinant rpsG and candidate sRNAs

    • Developing reporter systems to monitor effects of specific sRNA-rpsG interactions on translation in vivo

Recent studies have identified several sRNAs in E. faecalis that localize to the 30S ribosomal fraction , raising interesting questions about their potential interactions with rpsG and effects on translation regulation.

What structural analysis approaches would be most effective for studying E. faecalis rpsG?

To advance structural understanding of E. faecalis rpsG, researchers should consider multiple complementary techniques:

  • X-ray crystallography:

    • Co-crystallization of rpsG with 16S rRNA fragments

    • Structure determination in the context of the entire 30S subunit

    • Comparison with known structures from other bacterial species

  • Cryo-electron microscopy:

    • Single-particle analysis of ribosomes containing rpsG

    • Focus on the head domain assembly and mRNA/tRNA interaction sites

    • Structural studies under various functional states of the ribosome

  • NMR spectroscopy:

    • Solution structure of isolated domains

    • RNA-protein interaction studies

    • Dynamics analyses of flexible regions

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Mapping conformational changes upon RNA binding

    • Identifying dynamic regions important for function

    • Comparing dynamics between wild-type and mutant proteins

These approaches can build upon existing structural studies of ribosomes from related Gram-positive bacteria, such as the crystal structure of the large ribosomal subunit from Staphylococcus aureus , which revealed species-specific features that may have functional implications for antibiotic binding and resistance.

How can researchers study the role of rpsG in ribosome assembly pathways specific to E. faecalis?

Investigating the role of rpsG in E. faecalis-specific ribosome assembly requires specialized methodologies:

  • In vitro reconstitution experiments:

    • Stepwise assembly of 30S subunits using purified components

    • Comparison of assembly kinetics with and without rpsG

    • Identification of E. faecalis-specific assembly intermediates

  • Time-resolved structural studies:

    • Cryo-EM visualization of assembly intermediates

    • Chemical probing of rRNA structure during assembly

    • Monitoring conformational changes in real-time using fluorescence techniques

  • In vivo assembly analysis:

    • Pulse-chase experiments with tagged ribosomal components

    • Depletion studies using controllable expression systems

    • Identification of assembly factors specific to E. faecalis

  • Comparative studies:

    • Analysis of rpsG binding kinetics across different bacterial species

    • Comparison of assembly maps between E. faecalis and model organisms

    • Investigation of species-specific assembly factors that may interact with rpsG

Research has established that assembly of the 30S subunit from E. coli ribosomes occurs via two assembly domains initiated by S4 and S7 proteins , suggesting a critical role for rpsG in nucleating assembly. Similar detailed assembly maps for E. faecalis would advance understanding of species-specific translation mechanisms.

How might recombinant rpsG be utilized in developing novel antimicrobial strategies against E. faecalis?

As an essential component of the translation machinery, rpsG represents a potential target for novel antimicrobial development. Research applications include:

  • High-throughput screening platforms:

    • Development of assays using recombinant rpsG to screen for small molecule inhibitors

    • Structure-based drug design targeting E. faecalis-specific features of rpsG

    • Fragment-based approaches to identify binding pockets unique to E. faecalis rpsG

  • Peptide inhibitor development:

    • Design of peptides that mimic rpsG-rRNA interfaces

    • Creation of dominant-negative rpsG variants that disrupt ribosome assembly

    • Fusion of antimicrobial peptides to rpsG-binding domains for targeted delivery

  • Validation methodologies:

    • In vitro translation assays to confirm target engagement

    • Bacterial growth inhibition studies with E. faecalis clinical isolates

    • Resistance development monitoring through serial passage experiments

  • Combination therapy approaches:

    • Testing synergistic effects with existing antibiotics

    • Identifying pathways that sensitize cells to rpsG inhibition

    • Developing dual-target strategies to reduce resistance emergence

Given the emergence of vancomycin-resistant enterococci and other multidrug-resistant strains, developing novel targets like rpsG could provide valuable alternatives to conventional antibiotics.

What are the major challenges in working with recombinant E. faecalis rpsG and how can they be overcome?

Researchers face several technical challenges when working with recombinant rpsG:

  • Protein solubility issues:

    • Challenge: Ribosomal proteins often aggregate when expressed recombinantly

    • Solution: Use solubility-enhancing fusion tags (SUMO, MBP, TrxA), lower induction temperatures (16-18°C), and optimize buffer conditions (including stabilizing agents like arginine or low concentrations of detergents)

  • Nucleic acid contamination:

    • Challenge: rpsG's natural affinity for RNA can result in co-purification with bacterial nucleic acids

    • Solution: Include high-salt washes (500-750 mM NaCl), treat with nucleases during purification, and employ additional purification steps like heparin affinity chromatography

  • Functional validation:

    • Challenge: Confirming that recombinant rpsG retains native RNA-binding properties

    • Solution: Develop robust binding assays using defined rRNA fragments, compare binding profiles with native protein, and perform complementation tests in ribosome assembly assays

  • Stability concerns:

    • Challenge: Maintaining stable, active protein during storage and experiments

    • Solution: Identify optimal buffer conditions through thermal shift assays, consider flash-freezing small aliquots rather than freeze-thaw cycles, and test stabilizing additives like glycerol or trehalose

These challenges reflect the specialized nature of ribosomal proteins and their complex interactions within the translation machinery, requiring careful optimization for successful experimental outcomes.

How can researchers effectively distinguish between the roles of rpsG and other ribosomal proteins in E. faecalis studies?

Differentiating the specific contributions of rpsG from other ribosomal proteins requires sophisticated experimental approaches:

  • Genetic approaches:

    • Conditional expression systems for rpsG depletion studies

    • Site-directed mutagenesis targeting specific functional domains

    • Complementation experiments with chimeric proteins containing domains from other species

  • Biochemical methods:

    • Selective depletion of rpsG from purified ribosomes followed by functional assays

    • Reconstitution experiments with defined components

    • Competition assays between various ribosomal proteins for binding sites

  • Structural approaches:

    • Cross-linking studies to map proximity networks within the ribosome

    • Cryo-EM visualization of ribosomes with and without rpsG

    • Structure-guided mutations to disrupt specific interactions

  • Systems biology:

    • Transcriptomics and proteomics to monitor global effects of rpsG perturbation

    • Network analysis to distinguish direct from indirect effects

    • Comparative studies across multiple enterococcal species

Through these comprehensive approaches, researchers can build a more detailed understanding of rpsG's unique contributions to ribosome function in E. faecalis, beyond the general role shared by all ribosomal proteins.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.